$INGN
Inogen Inc

2023 Q2 Form 10-Q Financial Statement

#000095017023018300 Filed on May 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $83.64M $72.16M $80.39M
YoY Change -19.1% -10.23% -7.53%
Cost Of Revenue $49.59M $41.43M $45.38M
YoY Change -13.18% -8.7% -3.57%
Gross Profit $34.04M $30.73M $35.01M
YoY Change -26.4% -12.21% -12.21%
Gross Profit Margin 40.71% 42.59% 43.55%
Selling, General & Admin $41.52M $47.30M $43.23M
YoY Change -3.6% 9.43% 13.76%
% of Gross Profit 121.96% 153.92% 123.49%
Research & Development $4.293M $5.344M $5.364M
YoY Change -29.21% -0.37% 34.1%
% of Gross Profit 12.61% 17.39% 15.32%
Depreciation & Amortization $4.308M $4.086M $5.760M
YoY Change -26.33% -29.06% 12.99%
% of Gross Profit 12.65% 13.3% 16.45%
Operating Expenses $45.81M $52.65M $48.59M
YoY Change -6.76% 8.35% 15.68%
Operating Profit -$11.77M -$21.92M -$13.59M
YoY Change 309.18% 61.31% 537.24%
Interest Expense $1.646M $1.525M $29.00K
YoY Change 631.56% 5158.62% -71.0%
% of Operating Profit
Other Income/Expense, Net $337.0K $1.762M -$404.0K
YoY Change -167.81% -536.14% 59.68%
Pretax Income -$9.785M -$20.15M -$13.99M
YoY Change 190.1% 44.05% 486.58%
Income Tax $41.00K $196.0K $224.0K
% Of Pretax Income
Net Earnings -$9.826M -$20.35M -$14.21M
YoY Change 185.47% 43.16% 1841.8%
Net Earnings / Revenue -11.75% -28.2% -17.68%
Basic Earnings Per Share -$0.42 -$0.88 -$0.62
Diluted Earnings Per Share -$0.42 -$0.88 -$0.62
COMMON SHARES
Basic Shares Outstanding 23.12M 22.97M 22.75M
Diluted Shares Outstanding 23.15M 23.01M 22.75M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $170.1M $174.6M $223.4M
YoY Change -23.91% -21.86% -4.19%
Cash & Equivalents $167.7M $164.1M $213.4M
Short-Term Investments $2.459M $10.43M $9.989M
Other Short-Term Assets $15.38M $14.02M $25.24M
YoY Change -39.73% -44.46% 160.19%
Inventory $30.74M $38.82M $34.08M
Prepaid Expenses
Receivables $51.14M $53.89M $33.98M
Other Receivables $1.821M $1.859M $1.435M
Total Short-Term Assets $269.2M $283.1M $318.1M
YoY Change -14.65% -10.99% 2.72%
LONG-TERM ASSETS
Property, Plant & Equipment $69.46M $45.94M $39.33M
YoY Change 71.86% 16.81% 26.65%
Goodwill $32.89M $32.89M $32.93M
YoY Change 0.26% -0.14% -0.37%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.777M $2.590M $2.151M
YoY Change 34.35% 20.41% -88.44%
Total Long-Term Assets $105.1M $102.5M $156.5M
YoY Change -32.01% -34.49% -6.18%
TOTAL ASSETS
Total Short-Term Assets $269.2M $283.1M $318.1M
Total Long-Term Assets $105.1M $102.5M $156.5M
Total Assets $374.4M $385.7M $474.6M
YoY Change -20.36% -18.74% -0.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.30M $18.04M $18.11M
YoY Change 78.92% -0.36% 23.98%
Accrued Expenses $20.77M $19.78M $16.17M
YoY Change -1.62% 22.35% -3.2%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $59.37M $63.38M $59.82M
YoY Change 0.05% 5.94% 7.79%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $40.21M $41.00M $56.51M
YoY Change -25.81% -27.45% -12.66%
Total Long-Term Liabilities $40.21M $41.00M $56.51M
YoY Change -25.81% -27.45% -12.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $59.37M $63.38M $59.82M
Total Long-Term Liabilities $40.21M $41.00M $56.51M
Total Liabilities $99.57M $104.4M $116.3M
YoY Change -12.3% -10.28% -3.22%
SHAREHOLDERS EQUITY
Retained Earnings -$44.68M -$34.85M $55.06M
YoY Change -186.55% -163.3%
Common Stock $319.4M $316.2M $302.0M
YoY Change 4.73% 4.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $274.8M $281.3M $358.3M
YoY Change
Total Liabilities & Shareholders Equity $374.4M $385.7M $474.6M
YoY Change -20.36% -18.74% -0.4%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$9.826M -$20.35M -$14.21M
YoY Change 185.47% 43.16% 1841.8%
Depreciation, Depletion And Amortization $4.308M $4.086M $5.760M
YoY Change -26.33% -29.06% 12.99%
Cash From Operating Activities $4.030M -$6.301M -$18.10M
YoY Change -27.14% -65.18% -732.8%
INVESTING ACTIVITIES
Capital Expenditures $8.611M $1.076M $1.366M
YoY Change -266.36% -21.23% -9.89%
Acquisitions
YoY Change
Other Investing Activities $8.071M -$10.30M $91.00K
YoY Change -19.69% -11419.78% -98.53%
Cash From Investing Activities -$540.0K -$17.11M -$4.052M
YoY Change -111.08% 322.26% -510.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -33.00K 559.0K -108.0K
YoY Change -67.33% -617.59% -102.44%
NET CHANGE
Cash From Operating Activities 4.030M -6.301M -18.10M
Cash From Investing Activities -540.0K -17.11M -4.052M
Cash From Financing Activities -33.00K 559.0K -108.0K
Net Change In Cash 3.457M -22.88M -22.13M
YoY Change -66.45% 3.4% -374.78%
FREE CASH FLOW
Cash From Operating Activities $4.030M -$6.301M -$18.10M
Capital Expenditures $8.611M $1.076M $1.366M
Free Cash Flow -$4.581M -$7.377M -$19.46M
YoY Change -142.79% -62.1% -1548.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001294133
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-36309
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
INOGEN, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0989359
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
301 Coromar Drive
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Goleta
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
93117
CY2023Q1 dei City Area Code
CityAreaCode
(805)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
562-0500
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
INGN
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23121377
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
164137000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
187014000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2622000
CY2023Q1 us-gaap Assets
Assets
385674000
CY2022Q4 us-gaap Assets
Assets
405041000
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
32183000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
33974000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10757000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11190000
CY2023Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
8075000
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
7790000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3570000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3515000
CY2023Q1 ingn Contract With Customer Liability And Lease Deferred Revenue Current
ContractWithCustomerLiabilityAndLeaseDeferredRevenueCurrent
8794000
CY2022Q4 ingn Contract With Customer Liability And Lease Deferred Revenue Current
ContractWithCustomerLiabilityAndLeaseDeferredRevenueCurrent
8880000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
63379000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
65349000
CY2023Q1 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
12018000
CY2023Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
10428000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
53885000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
62725000
CY2023Q1 us-gaap Inventory Net
InventoryNet
38822000
CY2022Q4 us-gaap Inventory Net
InventoryNet
34093000
CY2023Q1 us-gaap Income Tax Receivable
IncomeTaxReceivable
1859000
CY2022Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
1626000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14016000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19187000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
283147000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
304645000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45942000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
43269000
CY2023Q1 us-gaap Goodwill
Goodwill
32887000
CY2022Q4 us-gaap Goodwill
Goodwill
32852000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21108000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21653000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2590000
CY2022Q4 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
12123000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19179000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19764000
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
9801000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
10399000
CY2023Q1 us-gaap Liabilities
Liabilities
104377000
CY2022Q4 us-gaap Liabilities
Liabilities
107635000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
23120786
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23120786
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22941643
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22941643
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
23000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
23000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
316127000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
312126000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-34849000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14500000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-243000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
281297000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
297406000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
385674000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
405041000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
55887000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
67402000
CY2023Q1 ingn Rental Revenue Net
RentalRevenueNet
16275000
CY2022Q1 ingn Rental Revenue Net
RentalRevenueNet
12983000
CY2023Q1 us-gaap Revenues
Revenues
72162000
CY2022Q1 us-gaap Revenues
Revenues
80385000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
33964000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
39500000
CY2023Q1 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
3078000
CY2022Q1 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
2638000
CY2023Q1 ingn Cost Of Rental
CostOfRental
7465000
CY2022Q1 ingn Cost Of Rental
CostOfRental
5879000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
41429000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
45379000
CY2023Q1 ingn Gross Profit Sales Revenue
GrossProfitSalesRevenue
21923000
CY2022Q1 ingn Gross Profit Sales Revenue
GrossProfitSalesRevenue
27902000
CY2023Q1 ingn Gross Profit Rental Revenue
GrossProfitRentalRevenue
8810000
CY2022Q1 ingn Gross Profit Rental Revenue
GrossProfitRentalRevenue
7104000
CY2023Q1 us-gaap Gross Profit
GrossProfit
30733000
CY2022Q1 us-gaap Gross Profit
GrossProfit
35006000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-14214000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5344000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5364000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
28441000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
28039000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18863000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15189000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
52648000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
48592000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-21915000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-13586000
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1525000
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
29000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
237000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-433000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1762000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-404000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20153000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13990000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
196000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
224000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-20349000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-14214000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
170000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-203000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-528000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-454000
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-74000
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
69000
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-8000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
239000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-285000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20110000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-14499000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.88
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.88
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23009617
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22754421
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23009617
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22754421
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
370227000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2665000
CY2022Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
915000
CY2022Q1 ingn Stock Issued During Period Value Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits
958000
CY2022Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
94000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-285000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
358285000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
29000
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-864000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6301000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
297406000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3442000
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
630000
CY2023Q1 ingn Stock Issued During Period Value Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueVestingOfRestrictedStockUnits
454000
CY2023Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
1000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
384000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-20349000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
239000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
281297000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-20349000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-14214000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4086000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5760000
CY2023Q1 ingn Gain Loss On Write Off Of Rental Units And Other Assets
GainLossOnWriteOffOfRentalUnitsAndOtherAssets
-1099000
CY2022Q1 ingn Gain Loss On Write Off Of Rental Units And Other Assets
GainLossOnWriteOffOfRentalUnitsAndOtherAssets
-706000
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
21000
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
52000
CY2023Q1 ingn Provision For Sales Returns And Doubtful Accounts
ProvisionForSalesReturnsAndDoubtfulAccounts
2258000
CY2022Q1 ingn Provision For Sales Returns And Doubtful Accounts
ProvisionForSalesReturnsAndDoubtfulAccounts
2953000
CY2023Q1 us-gaap Inventory Write Down
InventoryWriteDown
603000
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
934000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3442000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2665000
CY2022Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
630000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6726000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12802000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6362000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2515000
CY2023Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
233000
CY2022Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
92000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5173000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-764000
CY2023Q1 ingn Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-550000
CY2022Q1 ingn Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-832000
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-47000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-66000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1845000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6539000
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-436000
CY2022Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-8465000
CY2023Q1 ingn Increase Decrease In Warranty Reserve
IncreaseDecreaseInWarrantyReserve
180000
CY2022Q1 ingn Increase Decrease In Warranty Reserve
IncreaseDecreaseInWarrantyReserve
-633000
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-684000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-231000
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-79000
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-535000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18098000
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
10359000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1076000
CY2022Q1 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
1030000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1366000
CY2023Q1 ingn Payments To Produce And Purchase Rental Equipment
PaymentsToProduceAndPurchaseRentalEquipment
5733000
CY2022Q1 ingn Payments To Produce And Purchase Rental Equipment
PaymentsToProduceAndPurchaseRentalEquipment
2777000
CY2023Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
58000
CY2022Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
91000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17110000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4052000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
384000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
29000
CY2023Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
630000
CY2022Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
915000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
455000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1052000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
559000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-108000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-25000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
133000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-22877000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-22125000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
187014000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
235524000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
164137000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
213399000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
418000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
372000
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
65000
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
91000
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
10837000
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases these estimates and assumptions upon historical experience, existing and known circumstances, authoritative accounting pronouncements and other factors that management believes to be reasonable. Significant areas requiring the use of management estimates relate to revenue recognition, warranty reserves and expense, determining the stand-alone selling price (SSP) and service period of performance obligations, rental asset valuations and write-downs, accounts receivable allowances for bad debts, returns and adjustments, impairment of goodwill, impairment of long-lived assets, stock-based compensation expense, and income taxes. Actual results could differ from these estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
239000
CY2023Q1 us-gaap Cash
Cash
23864000
CY2022Q4 us-gaap Cash
Cash
27970000
CY2023Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
99048000
CY2022Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
113534000
CY2023Q1 us-gaap Asset Backed Securities At Carrying Value
AssetBackedSecuritiesAtCarryingValue
5985000
CY2022Q4 us-gaap Asset Backed Securities At Carrying Value
AssetBackedSecuritiesAtCarryingValue
6474000
CY2023Q1 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
14920000
CY2022Q4 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
18939000
CY2023Q1 ingn Institutional Insured Liquidity Deposit Savings
InstitutionalInsuredLiquidityDepositSavings
20320000
CY2022Q4 ingn Institutional Insured Liquidity Deposit Savings
InstitutionalInsuredLiquidityDepositSavings
20097000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
164137000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
187014000
CY2023Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
10428000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
53885000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
62725000
CY2023Q1 ingn Accrued Purchasing Card Liability
AccruedPurchasingCardLiability
3459000
CY2022Q4 ingn Accrued Purchasing Card Liability
AccruedPurchasingCardLiability
2606000
CY2023Q1 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
1311000
CY2023Q1 ingn Doubtful Accounts
DoubtfulAccounts
156000
CY2022Q4 ingn Doubtful Accounts
DoubtfulAccounts
77000
CY2023Q1 ingn Allowances For Sales Returns
AllowancesForSalesReturns
699000
CY2022Q4 ingn Allowances For Sales Returns
AllowancesForSalesReturns
483000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
855000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
560000
CY2023Q1 ingn Percentage Of Non Us Revenue Invoiced In Euros
PercentageOfNonUSRevenueInvoicedInEuros
0.770
CY2022Q1 ingn Percentage Of Non Us Revenue Invoiced In Euros
PercentageOfNonUSRevenueInvoicedInEuros
0.732
CY2023Q1 us-gaap Revenues
Revenues
72162000
CY2022Q1 us-gaap Revenues
Revenues
80385000
CY2023Q1 ingn Transfer Of Inventory To Rental Equipment
TransferOfInventoryToRentalEquipment
1013000
CY2022Q1 ingn Transfer Of Inventory To Rental Equipment
TransferOfInventoryToRentalEquipment
533000
CY2023Q1 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
25689000
CY2022Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
26496000
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
14291000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9324000
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1158000
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1727000
CY2023Q1 us-gaap Inventory Net
InventoryNet
38822000
CY2022Q4 us-gaap Inventory Net
InventoryNet
34093000
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
480000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
492000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4060000
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3613000
CY2023Q1 ingn Rental Equipment Allowance
RentalEquipmentAllowance
2765000
CY2022Q4 ingn Rental Equipment Allowance
RentalEquipmentAllowance
2255000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
97757000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
95113000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
51815000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
51844000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45942000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
43269000
CY2023Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022Q4 us-gaap Goodwill
Goodwill
32852000
CY2023Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-35000
CY2023Q1 us-gaap Goodwill
Goodwill
32887000
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
18043000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
18237000
CY2023Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
8688000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1513000
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.029
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
4002000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
3464000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
2787000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
2803000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1802000
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
32183000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
33974000
CY2023Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2076000
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2620000
CY2023Q1 ingn Accrued Wages And Other Payroll Related Items Current
AccruedWagesAndOtherPayrollRelatedItemsCurrent
5043000
CY2022Q4 ingn Accrued Wages And Other Payroll Related Items Current
AccruedWagesAndOtherPayrollRelatedItemsCurrent
4967000
CY2023Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
3449000
CY2022Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
3133000
CY2023Q1 ingn Accrued Employee Stock Purchase Plan Deductions
AccruedEmployeeStockPurchasePlanDeductions
189000
CY2022Q4 ingn Accrued Employee Stock Purchase Plan Deductions
AccruedEmployeeStockPurchasePlanDeductions
470000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10757000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11190000
CY2023Q1 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
options to extend the leases for up to 5 years.
CY2023Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2023Q1 ingn Rent Expense Including Short Term Lease Cost
RentExpenseIncludingShortTermLeaseCost
972000
CY2022Q1 ingn Rent Expense Including Short Term Lease Cost
RentExpenseIncludingShortTermLeaseCost
971000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
994000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1008000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
957000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
975000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
264000
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M6D
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.030
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
2842000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
8675000
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
44.19
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
24573000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1824000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
22749000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3570000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19179000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
22749000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-20349000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-14214000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23009617
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22754421
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23009617
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22754421
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.88
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.88
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23009617
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22754421
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
228281
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
88193
CY2023Q1 ingn Weighted Average Number Of Diluted Shares Outstanding Based On Net Loss
WeightedAverageNumberOfDilutedSharesOutstandingBasedOnNetLoss
23237898
CY2022Q1 ingn Weighted Average Number Of Diluted Shares Outstanding Based On Net Loss
WeightedAverageNumberOfDilutedSharesOutstandingBasedOnNetLoss
22842614
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
778267
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
958132
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
41933000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
348284
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.21
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y5M4D
CY2022 ingn Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValuePerShare
2.07
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
54432
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.03
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4125
CY2023Q1 ingn Share Based Compensation Arrangement By Share Based Payment Award Per Share Price Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerSharePriceForfeited
44.19
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
289727
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
51.19
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y2M19D
CY2023Q1 ingn Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value Per Share
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValuePerShare
0.04
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
289727
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
51.19
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P0Y2M19D
CY2023Q1 ingn Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Vested And Exercisable Per Share Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndExercisablePerShareAverageIntrinsicValue
0.04
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
289727
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
51.19
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P0Y2M19D
CY2023Q1 ingn Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Vested And Expected To Vest Per Share Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsVestedAndExpectedToVestPerShareAverageIntrinsicValue
0.04
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
735000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
84000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3442000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2665000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3442000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2665000
CY2023Q1 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
111400000
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
19913000
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
13726000
CY2023Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
1681000
CY2022 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
10416000
CY2023Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
1540000
CY2022 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
8234000
CY2023Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3041000
CY2022 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
12463000
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
20093000
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
19913000
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1674000
CY2023Q1 ingn Contract With Customer Performance Obligations To Be Satisfied In Future Periods
ContractWithCustomerPerformanceObligationsToBeSatisfiedInFuturePeriods
869000
CY2023Q1 us-gaap Restructuring Costs
RestructuringCosts
1809000
CY2023Q1 us-gaap Derivative Remaining Maturity1
DerivativeRemainingMaturity1
P1M
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0
CY2022Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-74000
CY2023Q1 ingn Number Of Contract Ineffective Hedges
NumberOfContractIneffectiveHedges
0
CY2022Q1 ingn Number Of Contract Ineffective Hedges
NumberOfContractIneffectiveHedges
0
CY2023Q1 ingn Number Of Contract Designated Hedges
NumberOfContractDesignatedHedges
0
CY2023Q1 ingn Number Of Contract Non Designated Hedges
NumberOfContractNonDesignatedHedges
1
CY2022Q1 ingn Number Of Contract Designated Hedges
NumberOfContractDesignatedHedges
8
CY2022Q1 ingn Number Of Contract Non Designated Hedges
NumberOfContractNonDesignatedHedges
1

Files In Submission

Name View Source Status
0000950170-23-018300-index-headers.html Edgar Link pending
0000950170-23-018300-index.html Edgar Link pending
0000950170-23-018300.txt Edgar Link pending
0000950170-23-018300-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ingn-20230331.htm Edgar Link pending
ingn-20230331.xsd Edgar Link pending
ingn-ex21_1.htm Edgar Link pending
ingn-ex31_1.htm Edgar Link pending
ingn-ex31_2.htm Edgar Link pending
ingn-ex32_1.htm Edgar Link pending
ingn-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ingn-20230331_cal.xml Edgar Link unprocessable
ingn-20230331_def.xml Edgar Link unprocessable
ingn-20230331_lab.xml Edgar Link unprocessable
ingn-20230331_pre.xml Edgar Link unprocessable
ingn-20230331_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending